Modulim Granted CPT Code from the American Medical Association for its Noninvasive Microvascular Assessment Technology

(BUSINESS WIRE) — Modulim, the global leader in noninvasive microvascular assessment using spatial frequency domain imaging (SFDI), has announced that the American Medical Association (AMA) has granted a Current Procedural Terminology (CPT^®) Proprietary Laboratory Analyses (PLA) Code (0061U) for the transcutaneous measurement of tissue oxygenation and hemoglobin using SFDI.

The CPT code allows for reimbursement when clinicians use Modulim’s SFDI and multispectral analysis technology to capture, analyze and report the quantitative values and 2D distribution maps for five biomarkers in tissue. This information may be helpful when assessing patients with potential circulatory compromise.

The Centers for Medicare and Medicaid Services (CMS) has priced the PLA code at $27.85 per image on the 2019 Medicare Clinical Laboratory Fee Schedule, effective immediately. The CPT code and pricing will allow healthcare providers to bill and receive payment when testing eligible patients.

” Modulim’s SFDI technology is a vital microvascular assessment tool to identify specific areas of compromised circulation. This can help us manage the care of patients with peripheral artery disease, slow-healing wounds and diabetic foot problems,” said Phillip E. Ward, D.P.M., a podiatrist at Cape Fear Valley Foot and Ankle Center in North Carolina.

CPT codes are granted and maintained by the AMA CPT Editorial Panel and are widely used by government payers, including Medicare and Medicaid, and commercial health plans to describe healthcare services and procedures for reimbursement.

To request a product demo or for more information about SFDI, visit modulim.com.

¹ 2019 Medical Clinical Laboratory Fee Schedule is available at http://www.cms.hhs.gov

² CPT is a registered trademark of the American Medical Association.

³Clarifi is a registered trademark of Modulim. See more at https://modulim.com/trademarks